Spire Healthcare Group’s (SPI) “Add” Rating Reiterated at Numis Securities

Numis Securities reiterated their add rating on shares of Spire Healthcare Group (LON:SPI) in a report released on Tuesday morning. Numis Securities currently has a GBX 296 ($4.01) price target on the stock.

A number of other research analysts also recently commented on SPI. Berenberg Bank reissued a hold rating and issued a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research report on Thursday, September 21st. Jefferies Group decreased their price objective on shares of Spire Healthcare Group from GBX 350 ($4.75) to GBX 259 ($3.51) and set a hold rating for the company in a research report on Monday, September 25th. Liberum Capital reissued a hold rating and issued a GBX 270 ($3.66) price objective on shares of Spire Healthcare Group in a research report on Tuesday, October 10th. Finally, JPMorgan Chase & Co. reissued a neutral rating and issued a GBX 339 ($4.60) price objective on shares of Spire Healthcare Group in a research report on Thursday, January 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of GBX 309.17 ($4.19).

Shares of Spire Healthcare Group (LON SPI) traded down GBX 4.60 ($0.06) on Tuesday, hitting GBX 249.20 ($3.38). 588,521 shares of the stock were exchanged, compared to its average volume of 1,280,000. Spire Healthcare Group has a 52 week low of GBX 218.20 ($2.96) and a 52 week high of GBX 362.10 ($4.91). The company has a market cap of $1,020.00 and a P/E ratio of 3,560.00.

In other Spire Healthcare Group news, insider Peter R. Bamford acquired 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The stock was acquired at an average price of GBX 240 ($3.25) per share, for a total transaction of £12,000 ($16,273.39). Also, insider Justin Ash acquired 84,500 shares of the company’s stock in a transaction on Thursday, November 23rd. The stock was acquired at an average price of GBX 237 ($3.21) per share, with a total value of £200,265 ($271,582.59).

TRADEMARK VIOLATION WARNING: “Spire Healthcare Group’s (SPI) “Add” Rating Reiterated at Numis Securities” was reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.com-unik.info/2018/01/19/spire-healthcare-groups-spi-add-rating-reiterated-at-numis-securities.html.

About Spire Healthcare Group

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit